Tracey Perry
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Biotechnology top 10%
- Cancer Research and Treatments
Papers in
-
- Histone Deacetylase Inhibitors Research 2
- Biochemical and Molecular Research 2
- Epigenetics and DNA Methylation 2
- Oncology 3
- CAR-T cell therapy research 2
- Co-authors
- Pamela Kearns (7 shared papers)Carmela De Santo (3 shared papers)Francis Mussai (3 shared papers)Paul Cheng (2 shared papers)Andrew D. Beggs (2 shared papers)Sharon A. Egan (1 shared paper)Justin Loke (1 shared paper)Ciarán Woodman (2 shared papers)
- Journals
- Cancers (2 papers)International Journal of Cancer (2 papers)Oncogene (1 paper)Haematologica (1 paper)PLoS ONE (1 paper)
- Partner nations
- United KingdomCzechiaHong Kong
In The Last Decade
Tracey Perry
9 papers receiving 358 citations
Peers
Comparison fields: 5 of 51
- Hematology 113
- Biotechnology 64
- Cancer Research 103
- Biochemistry 36
- Immunology 74
Countries citing papers authored by Tracey Perry
This map shows the geographic impact of Tracey Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracey Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracey Perry more than expected).
Fields of papers citing papers by Tracey Perry
This network shows the impact of papers produced by Tracey Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracey Perry. The network helps show where Tracey Perry may publish in the future.
Co-authors
The 25 scholars most cited alongside Tracey Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 126 | |
| 2 | 2013 | 63 | |
| 3 | 2018 | 60 | |
| 4 | 2017 | 53 | |
| 5 | 2014 | 26 | |
| 6 | 2018 | 20 | |
| 7 | 2014 | 6 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 0 |
About Tracey Perry
Tracey Perry is a scholar working on Molecular Biology, Oncology, Biotechnology, Immunology and Genetics, having authored 10 papers that have together received 360 indexed citations. Recurring topics across this work include Cancer Research and Treatments (3 papers), Immune Cell Function and Interaction (3 papers), Histone Deacetylase Inhibitors Research (2 papers), Biochemical and Molecular Research (2 papers), CAR-T cell therapy research (2 papers), Epigenetics and DNA Methylation (2 papers), Pancreatic function and diabetes (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (113 citations), Biotechnology (64 citations), Cancer Research (103 citations), Biochemistry (36 citations) and Immunology (74 citations). Tracey Perry has collaborated with scholars based in United Kingdom, Czechia and Hong Kong. Frequent co-authors include Pamela Kearns, Carmela De Santo, Francis Mussai, Paul Cheng, Andrew D. Beggs, Sharon A. Egan, Justin Loke, Ciarán Woodman, Anthony W.I. Lo and Elena Odintsova. Their work appears in journals such as Cancers, International Journal of Cancer, Oncogene, Haematologica and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.